Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma.

Rao S, Sengupta R, Choe EJ, Woerner BM, Jackson E, Sun T, Leonard J, Piwnica-Worms D, Rubin JB.

PLoS One. 2012;7(3):e33005. doi: 10.1371/journal.pone.0033005. Epub 2012 Mar 12.

2.

Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.

Woerner BM, Luo J, Brown KR, Jackson E, Dahiya SM, Mischel P, Benovic JL, Piwnica-Worms D, Rubin JB.

Mol Cancer Res. 2012 Jan;10(1):156-66. doi: 10.1158/1541-7786.MCR-11-0411. Epub 2011 Nov 15.

3.

CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma.

Sengupta R, Dubuc A, Ward S, Yang L, Northcott P, Woerner BM, Kroll K, Luo J, Taylor MD, Wechsler-Reya RJ, Rubin JB.

Cancer Res. 2012 Jan 1;72(1):122-32. doi: 10.1158/0008-5472.CAN-11-1701. Epub 2011 Nov 3.

4.

Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.

Goldhoff P, Warrington NM, Limbrick DD Jr, Hope A, Woerner BM, Jackson E, Perry A, Piwnica-Worms D, Rubin JB.

Clin Cancer Res. 2008 Dec 1;14(23):7717-25. doi: 10.1158/1078-0432.CCR-08-0827.

5.

Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.

McCandless EE, Piccio L, Woerner BM, Schmidt RE, Rubin JB, Cross AH, Klein RS.

Am J Pathol. 2008 Mar;172(3):799-808. doi: 10.2353/ajpath.2008.070918. Epub 2008 Feb 14.

6.

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

Warrington NM, Woerner BM, Daginakatte GC, Dasgupta B, Perry A, Gutmann DH, Rubin JB.

Cancer Res. 2007 Sep 15;67(18):8588-95.

7.

Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo.

Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB.

Cancer Res. 2007 Jan 15;67(2):651-8.

8.
9.

Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies.

Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB.

Cancer Res. 2005 Dec 15;65(24):11392-9.

10.

Renal effects of selective cyclooxygenase inhibition in experimental liver disease.

López-Parra M, Clària J, Planagumà A, Titos E, Masferrer JL, Woerner BM, Koki AT, Jiménez W, Arroyo V, Rivera F, Rodés J.

Adv Exp Med Biol. 2003;525:133-6. No abstract available.

PMID:
12751752
11.

Cyclooxygenase-2 in human pathological disease.

Koki A, Khan NK, Woerner BM, Dannenberg AJ, Olson L, Seibert K, Edwards D, Hardy M, Isakson P, Masferrer JL.

Adv Exp Med Biol. 2002;507:177-84. Review.

PMID:
12664583
12.

Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.

Hardy MM, Seibert K, Manning PT, Currie MG, Woerner BM, Edwards D, Koki A, Tripp CS.

Arthritis Rheum. 2002 Jul;46(7):1789-803.

13.

Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.

Koki AT, Khan NK, Woerner BM, Seibert K, Harmon JL, Dannenberg AJ, Soslow RA, Masferrer JL.

Prostaglandins Leukot Essent Fatty Acids. 2002 Jan;66(1):13-8. Review.

PMID:
12051953
14.

Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.

López-Parra M, Clària J, Planagumà A, Titos E, Masferrer JL, Woerner BM, Koki AT, Jiménez W, Altuna R, Arroyo V, Rivera F, Rodés J.

Br J Pharmacol. 2002 Feb;135(4):891-900.

15.

Gene isolation and characterization of two acyl CoA oxidases from soybean with broad substrate specificities and enhanced expression in the growing seedling axis.

Agarwal AK, Qi Y, Bhat DG, Woerner BM, Brown SM.

Plant Mol Biol. 2001 Nov;47(4):519-31. Erratum in: Plant Mol Biol 2001 Dec;47(6):827.

PMID:
11669577
16.

Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.

Khan KN, Masferrer JL, Woerner BM, Soslow R, Koki AT.

Scand J Gastroenterol. 2001 Aug;36(8):865-9.

PMID:
11495083
17.

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT.

Cancer. 2000 Dec 15;89(12):2637-45.

PMID:
11135226
18.

Fungal pathogen protection in potato by expression of a plant defensin peptide.

Gao AG, Hakimi SM, Mittanck CA, Wu Y, Woerner BM, Stark DM, Shah DM, Liang J, Rommens CM.

Nat Biotechnol. 2000 Dec;18(12):1307-10.

PMID:
11101813
19.

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K.

Cancer Res. 2000 Mar 1;60(5):1306-11.

20.

Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder.

Mohammed SI, Knapp DW, Bostwick DG, Foster RS, Khan KN, Masferrer JL, Woerner BM, Snyder PW, Koki AT.

Cancer Res. 1999 Nov 15;59(22):5647-50.

21.

Analysis of stained objects in histological sections by spectral imaging and differential absorption.

Ornberg RL, Woerner BM, Edwards DA.

J Histochem Cytochem. 1999 Oct;47(10):1307-14.

PMID:
10490459
22.

Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.

Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ 3rd.

Cancer Res. 1999 Mar 1;59(5):987-90.

23.

Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.

Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL, Dannenberg AJ.

Cancer Res. 1999 Mar 1;59(5):991-4.

Supplemental Content

Loading ...
Support Center